Abstract/Details

Metabolic syndrome and prostate cancer


2009 2009

Other formats: Order a copy

Abstract (summary)

Background. The association between metabolic syndrome (MetS) and prostate cancer, two major public health problems, carries with it potentially significant implications. Chronic inflammation, which correlates with MetS, might also promote cancer growth. The related data remain controversial. We aimed to help solve the debates using a prospective study in Taiwan.

Methods. This dissertation contains three separate parts related to MetS and prostate cancer. Part I is a literature review on the interested association. Part II is a case-cohort study that tested the hypothesis if the MetS (WHO-criteria) altered risk of prostate cancer death using a health screening population of 54,751 cancer-free men enrolled between 1996 and 2003. We followed up their mortality status via the National Death Registry through 2005. Four thousand men were randomly selected as the subcohort. Part III is a case-cohort study that tested whether high-sensitivity C-reactive protein (hsCRP), a marker of inflammation, increased risk of death from overall cancer including prostate cancer, using the same study population in part II.

Results. Part I: data on the interested association are limited and inconsistent. Part II and III: After a median 7.1 years of follow-up, 36 cases of prostate cancer death and 1,170 cases of overall cancer death were ascertained. Among the MetS components, only hyperglycemia was a significant risk factor for prostate cancer death; but the MetS alone was not. Compared to men without hyperglycemia, men with pre-diabetes, the MetS before onset of diabetes, and new-onset diabetes, had increased risk, but men with known diabetes at baseline had lower risk of prostate cancer death. High hsCRP at baseline was positively associated with risk of death from overall cancer (statistically significant) including prostate cancer (marginally significant), even with multivariate-adjustment.

Conclusions. The effects of each MetS components on risk of prostate cancer death were heterogeneous. Men in early stages of glycemia disorders had higher risk, while men in late stages of glycemia disorders had lower risk of prostate cancer death. Elevated hsCRP predicted increased risk of death from overall cancer, including prostate cancer. Measures that aim at reducing hyperglycemia and chronic inflammation deserve serious attention in cancer prevention programs.

Indexing (details)


Subject
Epidemiology
Classification
0766: Epidemiology
Identifier / keyword
Health and environmental sciences; Asian; C-reactive protein; Hyperglycemia; Metabolic syndrome; Mortality; Prostate cancer
Title
Metabolic syndrome and prostate cancer
Author
Chung, Hui-Ming
Number of pages
200
Publication year
2009
Degree date
2009
School code
0098
Source
DAI-B 69/12, Dissertation Abstracts International
Place of publication
Ann Arbor
Country of publication
United States
ISBN
9780549936572
Advisor
Trock, Bruce J.; Platz, Elizabeth A.
University/institution
The Johns Hopkins University
University location
United States -- Maryland
Degree
Ph.D.
Source type
Dissertations & Theses
Language
English
Document type
Dissertation/Thesis
Dissertation/thesis number
3339693
ProQuest document ID
304906240
Copyright
Database copyright ProQuest LLC; ProQuest does not claim copyright in the individual underlying works.
Document URL
http://search.proquest.com/docview/304906240
Access the complete full text

You can get the full text of this document if it is part of your institution's ProQuest subscription.

Try one of the following:

  • Connect to ProQuest through your library network and search for the document from there.
  • Request the document from your library.
  • Go to the ProQuest login page and enter a ProQuest or My Research username / password.